drugset / Trial / NCT00996164
Fixed 100 mg Every Evening of Flibanserin vs Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder
RandomizedParallel-groupDouble-blindTreatment
Summary
The object of this trial is to assess the safety and efficacy of a 24 week course of flibanserin for the treatment of hypoactive sexual desire disorder in premenopausal women.
Timeline
- Start
- 2009-10
- Primary completion
- 2010-12
- Completion
- 2011-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | flibanserin | Small molecule | 100 mg | Oral |